TrialPloS one2012

Low-dose oral sirolimus and the risk of menstrual-cycle disturbances and ovarian cysts: analysis of the randomized controlled SUISSE ADPKD trial.

Matthias Braun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.